Clinical Research Directory
Browse clinical research sites, groups, and studies.
[18F]-AraG PET Imaging in LA HNSCC
Sponsor: Indiana University
Summary
This study will use \[18F\]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.
Official title: [18F]-AraG PET Imaging for Enhanced Risk Stratification and Chemoradiotherapy Response Assessment in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2025-10-01
Completion Date
2027-10
Last Updated
2025-09-11
Healthy Volunteers
No
Conditions
Interventions
[18F]-AraG radiotracer
\[18F\]-AraG radiotracer, which occurs on the first and sixteenth day of treatment.
Chemotherapy
Concurrent chemoradiotherapy (CRT) with weekly doses of cisplatin.
Radiotherapy
Concurrent chemoradiotherapy (CRT) of 70Gy of radiation dose in 33 fractions.
Locations (1)
Indiana University
Indianapolis, Indiana, United States